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Abstract
Background: The Healthy Nordic Food Index (HNFI) has been associated
with beneficial effects on markers of cardiovascular disease (CVD). Whether
such effects are present among patients with established coronary heart dis-
ease is unknown. In the present study, we investigated the association
between adherence to the HNFI and the risk of acute myocardial infarction
(AMI) (fatal or nonfatal) and death among patients with stable angina pec-
toris.
Methods: In the Western Norway B-vitamin Intervention Trial, participants
completed a 169-item semi-quantitative food frequency questionnaire. The
HNFI was calculated from six food groups (fish, cabbage, apples/pears, root
vegetables, whole grain bread and oatmeal), scoring 0–6. Three adherence
groups were defined: 0–1 points (low), 2–3 points (medium) or 4–6 points
(high). Cox regression analyses investigated associations between adherence
to the HNFI and outcomes.
Results: Among 2019 men (79.7%) and women with mean age of
61.7 years, 307 patients experienced an AMI event during a median (25th
and 75th percentiles) follow-up of 7.5 (6.3 and 8.7) years. Median follow-up
for total mortality was 10.5 (9.3 and 11.7) years; 171 patients died from
CVD and 380 from any cause. No association between HNFI and the risk
of AMI was detected. However, the HNFI was associated with a reduced risk
of all-cause death, both by linear estimates [hazard ratio (95% confidence
interval = 0.91 (0.84–0.98)] and by comparison of the highest with the low-
est adherence group [hazard ratio (95% confidence interval = 0.70 (0.52–
0.95)].
Conclusions: The results of the present study suggest that a Healthy Nordic
diet may reduce mortality in patients with established CVD.
Introduction
Cardiovascular disease (CVD) is the number one cause of
death globally, and 80% of all CVD deaths are a result of
acute myocardial infarction (AMI) or stroke (1). Despite
optimised medical treatment, patients suffering from coro-
nary heart disease and stable angina have an increased risk
of new cardiovascular events and mortality (2). There is no
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doubt that diet influences the development and progres-
sion of CVD. Dietary intakes rich in fish (3), vegetables (4)
or whole grain (5) have been shown to be inversely associ-
ated with CVD development and progression. Because
food intakes usually show high degrees of collinearity (6),
dietary pattern analysis has been developed to evaluate the
effect of the whole diet on disease development and pro-
gression (7,8).
Dietary pattern analysis can follow a hypothesis-free
data analysis (9) or follow the concept that a predefined
dietary pattern has a particular effect on disease (10–12). In
particular, the so-called Mediterranean Diet has been
described and investigated in relation to CVD. Adherence
to the diet is measured using a scoring system, where a
score (zero or one) is given for a certain amount of con-
sumption of each food component. Sex-specific median
intakes are used as a cut-off. The score then reflects
adherence to the diet and can be analysed with respect to
biomarkers or risk factors, and clinical outcomes (13).
The use of the Mediterranean Diet score may not be
suitable for populations in areas outside southern Europe
because the score would not reflect local dietary habits
and would thus cause misclassification (14). Thus, other
local food scores have been defined, especially in the Nor-
dic countries, which have a number of specific dietary
traditions in common (15). Among them, the Nordic diet
has been characterised (15,16) and analysed with respect to
biomarkers (17) and cardiovascular risk factors in healthy
and hypercholesterolemic populations (18,19). The Nordic
Diet is probably more acceptable for populations in the
Nordic countries and might be easier to adhere to than
the Mediterranean Diet (20,21).
However, there are different definitions of the Nordic
diet, depending on geographical location and focus of the
study (15). In the present study, we use the approach of
the Healthy Nordic Food Index (HNFI) based on scores
for intake of fish, cabbage, fruits and berries, root vegeta-
bles, whole grain or rye bread and oatmeal (14). It has
been shown that high adherence to the score is associated
with a healthier lifestyle (22) , as well as a lower risk of
myocardial infarction (23) and total mortality (14), in
healthy subjects. This led to the hypothesis that a high
score of the HNFI is protective of future AMI and cardio-
vascular and total mortality among patients at high risk.
Accordingly, we analysed whether adherence to the HNFI
was associated with the risk of AMI and mortality in a
cohort of Norwegian patients with stable angina pectoris.
Materials and methods
Study population
From 1999 to 2004, 3090 adult patients at two Norwegian
University Hospitals in Bergen and Stavanger undergoing
diagnostic coronary angiography because of suspected
coronary artery disease (CAD) or aortic stenosis were
recruited to the Western Norway B-Vitamin Interven-
tion Trial (WENBIT). The main aim was to investigate
clinical outcomes of homocysteine-lowering B-vitamin
treatment (24,25). No significant effect of the B-vitamin
intervention was found on cardiovascular outcomes or
mortality (25,26). Inclusion criteria for randomisation were
men and women aged 18 years or older undergoing coro-
nary angiography for suspected CAD and/or aortic valve
stenosis at two University hospitals in Western Norway.
Exclusion criteria were unavailability for follow-up, partici-
pation in other trials, known alcohol abuse, serious mental
illness, cancer disease or patients not filling out the food
frequency questionnaire (FFQ) (26). Information on dietary
habits was collected by a self-administered FFQ from 2484
participants. After further exclusion of participants who
had more than one blank page on the FFQ (n = 96) and
participants who had very low [<30 MJ (<717 kcal) for
women and <33 MJ (<789 kcal) for men] or very high
[<150 MJ (>3585 kcal) for women and <175 MJ
(>4182 kcal) for men] estimated daily energy intakes
(n = 37), FFQ data from 2351 participants were considered
to have satisfactory quality. Patients with a history of acute
coronary syndrome were excluded because of a tendency to
change their diet (27). Thus, data from 2019 patients with
stable angina patients were used for the current analysis
(Fig. 1). All participants provided their written consent.
The study protocol was in accordance with the principles
of the Declaration of Helsinki and approved by the Data
Inspectorate and the Regional Committee for Medical and
Health Research Ethics, and the Norwegian Medicines
Agency.
Food frequency questionnaire
The FFQ was handed out after coronary angiography dur-
ing inclusion in WENBIT, filled in at home and returned
to the study centre either at the follow-up visit scheduled
1 month later or by mail ahead of this appointment. The
10-page questionnaire included 169 food items grouped
according to Norwegian meal patterns and was designed
to obtain information on habitual food intake during the
past year. The frequency of consumption was given per
day, week or month, depending on the items in question.
Portion sizes were given as household measures or units
such as slices, pieces, spoons or glasses. Average daily
intake was used in the analyses. The FFQ was developed
at the Department of Nutrition at the University of Oslo
(Oslo, Norway) and has been validated (28–31). Estima-
tions of nutrient and food intakes were performed using
a food database and a bespoke software system (KOST-
BEREGNINGSSYSTEM, version 3.2; Department of Nutrition,
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University of Oslo, Oslo, Norway). This database is based
on the official Norwegian Food Table (30).
The Healthy Nordic Food Index
The HNFI includes dietary items likely to have beneficial
health effects when the consumption is high (14) and is
based on six typical food groups consumed in the Nordic
countries (fish, cabbage, apple and pears, root vegetables,
rye bread and oatmeal). Similar to a previous study (32), we
replaced rye bread with wholegrain bread because informa-
tion on rye bread specifically was not included in the FFQ.
The sex-specific medians for consumption of each food
group were calculated (see Supporting information,
Table S1). Participants with a dietary intake equal to or
above the median intake were given one point for each of
the six food groups, and zero points were given for
intakes below the median. The median intake for oatmeal
was zero g day1 for both women and men because more
than 50% of the cohort did not consume oatmeal.
Instead, participants with any intake received one point.
Accordingly, one point was assigned for the following
reported daily intakes for men: fish ≥103 g, cabbages
≥27 g, apples and pears ≥38 g, root vegetables ≥48 g, oat-
meal ≥1 g, whole grain bread ≥2 slices (80 g). For
women, one point was given for daily intakes: fish ≥78 g,
cabbages ≥27 g, apples and pears ≥38 g, root vegetables
≥50 g, oatmeal ≥1 g, whole grain bread ≥3 slices (120 g).
The total score was summed up for each participant
who could achieve a maximum score of six points (see
Supporting information, Table S2). To ensure a sufficient
number of cases within each exposure category, the sex-
specific scores were further categorised into three adher-
ence groups: low (0–1 points), medium (2–3 points) and
high (4–6 points) adherence.
Laboratory analyses and assessment of other covariates
Demographic, clinical and routine laboratory data were
obtained by study personnel at the two study centres, as
Figure 1 Flow of included and excluded patients to
the current study cohort. ACS, acute coronary
syndrome; FFQ, food frequency questionnaire.
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described previously (33). Standard blood laboratory
parameters were analysed from fresh samples in accor-
dance with routine protocols at the hospital laboratories
and the analytical information on measurements of
apolipoprotein A1, apolipoprotein B, cotinine and low-
density lipoprotein cholesterol is described in detail else-
where (27).
Diabetes mellitus was classified in accordance with the
existing diagnosis (prevalent diabetes either yes or no) or
based on baseline fasting serum glucose ≥7.0 mmol L1
or nonfasting glucose ≥11.1 mmol L1 (34). Smokers
include self-reported current smokers, those reported hav-
ing quit within the last 4 weeks and patients with plasma
cotinine ≥85 nmol L1 at baseline (35). Left ventricular
ejection fraction was determined by ventriculography or
echocardiography; values <50% were classified as
impaired systolic function. The extent of CAD was angio-
graphically graded as nonsignificant stenosis (luminal
narrowing <50%), or as having single-, double- or triple-
vessel disease (36).
Endpoints and follow-up
The study endpoints were fatal and nonfatal AMI, cardio-
vascular and all-cause death. Patients were followed until
1 January 2010 for AMI events through the Cardiovascu-
lar Disease in Norway project (CVDNOR www.cvdnor.
no) (37,38) and until 1 January 2013 for cardiovascular
and total death through the Norwegian Cause of Death
Registry. The incidence of cardiovascular death included
deaths coded as I00 to I96 or R99 according to the Inter-
national Classification of Disease, 10th Revsison (39).
Statistical analysis
Baseline and dietary variables are reported as the mean
(SD), medians (25th and 75th percentiles) or proportions
as appropriate. Dietary intakes of macronutrients are pre-
sented as proportions of total energy intake, whereas
intakes of food items are given as densities
(g 1000 kcal1). All participants were ranked according
to the three HNFI adherence groups (0–1, 2–3 and 4–6
points). An association between the HNFI adherence
groups and baseline variables was assessed using linear
regression for continuous variables and logistic regression
or chi-squared for categorical variables (Table 1).
Associations between adherence to the HNFI and sub-
sequent risk of endpoints during follow-up were evalu-
ated by Cox proportional hazard models. Risk
associations were explored by comparing the two highest
HNFI groups with the lowest adherence group (0–1
points) and by linear trends across these groups, as well
as according to the HNFI score. Hazard ratios (HRs) and
95% confidence intervals (CI) are reported. For the end-
point AMI, analyses were repeated for fatal and nonfatal
AMI, separately.
Three different models are presented for each outcome.
A basic model was controlled for age and sex (Model 1).
Additionally, we adjusted for energy intake (Model 2) to
reduce confounding by differences in energy intake. In
Model 3, we further adjusted for alcohol intake (g/day/
1000kcal) and clinically relevant covariates: diabetes melli-
tus (yes/no); hypertension (yes/no); physical activity
(never; 1 day week1; 2–3 times week1; at least
4 days week1); current smoking (yes/no); and use of sta-
tins at discharge form hospital (yes/no). Additional
adjustment for waist circumference, acetylsalicylic acid,
angiotensin-converting enzyme inhibitors and/or angio-
tensin receptor blockers, b-blockers, loop diuretics, left
ventricle ejection fraction, plasma concentration of
cholesterol, and a history of percutaneous coronary inter-
vention did not affect the estimates (data not shown);
thus, these factors were not included in the final analyses.
Kaplan–Meier survival plots were applied to illustrate
the survival time for sex-specific outcomes. Statistical
analyses were performed using SPSS, version 24 (IBM




Characteristics are presented across the three HNFI
adherence groups (Table 1). Overall, 19.4% of patients
were classified as having low adherence (0–1 points),
44.7% as having medium adherence (2–3 points) and
35.9% as having high adherence (4–6 points). The age of
subjects at inclusion ranged from 28 to 85 years, with a
mean (SD) age of 61.7 (10) years.
Participants who scored high on the HNFI were older
(P = 0.001), more likely to be men (P = 0.02), physically
active (P = 0.002) and to have a lower serum total
cholesterol (P < 0.001), low-density lipoprotein choles-
terol (P < 0.001), apolipoprotein B (P < 0.001) and
triglycerides (P = 0.01). These patients were also less
likely to be current smokers (P < 0.001), to have a his-
tory of percutaneous coronary intervention (P = 0.002)
and to have a reduced ejection fraction <50% (P = 0.01).
Acetylsalicylic acid (89%), statins (88%) and b-blockers
(77%) were used by a majority of the participants after
baseline coronary angiography. Participants with high
HNFI adherence were less likely to use loop diuretics
(P = 0.01).
High adherence to the HNFI corresponded to higher
intakes of total energy, higher energy percentage (E%)
from proteins and carbohydrates (P < 0.001 for all). As
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Table 1 Baseline characteristics of patients with stable angina pectoris
Characteristics Total
Healthy Nordic Food Index groups
P-trend†0–1 (lowest) 2–3 4–6 (highest)
Patients, n (%) 2019 392 (19.4) 903 (44.7) 724 (35.9)
Age (years) 61.8 (9.7)* 60.1 (10.3) 62.0 (10.1) 62.4 (8.8) 0.001
Male sex, n (%) 1610 (79.7) 309 (78.8) 698 (77.3) 603 (83.3) 0.03
Body mass index (kg m–²) 26.4 (3.7)* 26.4 (4.1) 26.3 (3.7) 26.4 (3.7) 0.62
Waist circumference (cm) 96.4 (11)* 96.3 (11.9) 96.1 (10.5) 96.9 (11.4) 0.27
Cardiovascular history, n (%)
Percutaneous coronary intervention 452 (22.4) 108 (27.6) 204 (22.6) 140 (19.3) 0.002
Coronary artery bypass graft surgery 290 (14.4) 49 (12.5) 126 (14.0) 115 (15.9) 0.11
Acute myocardial infarction 867 (42.9) 190 (48.5) 373 (41.3) 304 (42.0) 0.08
Coronary risk factors, n (%)
Hypertension 958 (47.4) 167 (42.6) 441 (48.8) 350 (48.3) 0.060
Diabetes mellitus‡ 622 (30.8) 111 (28.3) 289 (32.0) 222 (30.7) 0.29
Current smoker§ 593 (29.4) 159 (40.6) 265 (29.3) 169 (23.3) ˂0.001
Physical activity¶:
Never 109 (5.4) 29 (7.4) 52 (5.8) 28 (3.9) 0.002
1 day week1 375 (18.6) 95 (24.2) 169 (18.7) 11 (15.3)
2–3 times week1 641 (31.9) 105 (26.8) 281 (31.1) 255 (35.2)
At least 4 days week1 462 (23.0) 80 (20.4) 205 (22.7) 177 (24.4)
Clinical diagnosis before baseline coronary angiography, n (%)
Left ventricular ejection
fraction <50%, n (%)
268 (13.3) 69 (17.6) 115 (12.7) 84 (11.6) 0.01
Extend of CAD at baseline coronary angiography, n (%)
Nonsignificant CAD 248 (12.3) 55 (14.0) 124 (13.7) 69 (9.5) 0.13
Single-vessel disease 569 (28.2) 111 (28.3) 251 (27.8) 207 (28.6)
Double-vessel disease 549 (27.2) 110 (28.1) 244 (27.0) 195 (26.9)
Triple-vessel disease 653 (32.3) 116 (29.6) 284 (31.5) 253 (34.9)
Serum lipids at baseline
coronary angiography
Total cholesterol (mmol L1) 5.1 (1.2)* 5.2 (1.6) 5.1 (1.3) 4.9 (1.1) ˂0.001
Low-density lipoprotein
cholesterol (mmol L1)
3.1 (1.0)* 3.2 (1.1) 3.1 (1.0) 3.0 (1.0) ˂0.001
High-density lipoprotein
cholesterol (mmol L1)
1.3 (0.4)* 1.3 (0.4) 1.3 (0.5) 1.3 (0.3) 0.98
Apolipoprotein B (g L1)k 0.85 [0.71 and 1.02] 0.87 [0.73 and 1.06] 0.85 [0.72 and 1.02] 0.82 [0.69 and 1.00] ˂0.001
Apolipoprotein A1 (g L1)k 1.27 [1.10 and 1.44] 1.24 [1.09 and 1.44] 1.28 [1.11 and 1.46] 1.26 [1.11 and 1.42] 0.66
Triglycerides (mmol L1)k 1.53 [1.10 and 2.20] 1.59 [1.14 and 2.35] 1.59 [1.10 and 2.20] 1.48 [1.09 and 2.12] 0.01
Inflammation markers and renal function at baseline coronary angiography
C-reactive protein (mg L1)k 1.65 [0.81 and 3.27] 1.90 [0.96 and 3.69] 1.77 [0.86 and 3.36] 1.34 [0.73 and 2.81] 0.06
eGFR (mL min1) 89.7 (15.4)* 90.6 (17.0)* 89.3 (15.5)* 89.8 (14.3)* 0.57
Medications after baseline coronary angiography, n (%)
Acetylsalicylic acid 1801 (89.2) 347 (88.5) 810 (89.7) 644 (89.0) 0.92
Statins 1783 (88.3) 339 (86.5) 797 (88.3) 647 (89.4) 0.16
b-blockers 1547 (76.6) 310 (79.1) 681 (75.4) 556 (76.8) 0.54
ACE inhibitors and/or ARBs 403 (20.0) 82 (20.0) 174 (19.3) 147 (20.3) 0.48
Loop diuretics 187 (9.3) 49 (12.5) 83 (9.2) 55 (7.6) 0.01
ACE, angiotensin converting enzyme; ARBs, angiotensin receptor blockers; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate.
*Data are the mean (SD) (all such values).
†P-trend for Healthy Nordic Food Index groups 0–1, 2–3 and 4–6. Calculated with use of linear regression for continuous variables, logistic regres-
sion and chi-squared for categorical variables.
‡Diabetes, diagnosed or assessed according to baseline serum glucose levels ≥7.0 or a nonfasting glucose ≥11.1 mmol L1.
§Current smoker, based on self-report and cotinine levels >85 (includes ex-smokers <1 month).
¶Missing, n = 432 (21.4%); 0–1 = 79 (20.4%); 2–3 = 194 (21.5%); 4–6 = 151 (20.9%).
kMedian and percentiles [25th and 75th].
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expected, high adherence was associated with a higher
consumption of dietary fibre (P < 0.001), fish
(P < 0.001), whole grain bread (P < 0.001), vegetables
(P < 0.001) and fruit/ berries (P < 0.001). All intake was
energy adjusted. A high HNFI score was also associated
with a lower E% consumption of total fat (P < 0.001),
saturated fatty acids (SFA) (P < 0.001) and monounsatu-
rated fatty acids (P < 0.001), as well as lower intake of
processed meat (P < 0.001), cheese (P = 0.002), butter
(P < 0.001) and white bread (P < 0.001). All food items
were energy adjusted (Table 2).
Adherence to the Healthy Nordic diet and outcomes
Median (25th and 75th percentiles) length of follow-up
was 10.5 (9.3 and 11.7) years for mortality outcomes and
7.5 (6.3 and 8.7) years for AMI. A total of 171 partici-
pants died as a result of cardiovascular disease, 380 died
from any cause and 307 patients experienced at least one
nonfatal or fatal AMI.
No significant association between adherence to the
HNFI and the incidence of total AMI (Table 3) or for
nonfatal and fatal AMI separately (see Supporting infor-
mation, Table S3) was detected. For cardiovascular death,
a reduced risk was detected per 1-point increment in the
index [HR (95% CI) = 0.90 (0.81–1.01)], although this
was statistically insignificant. For all-cause death, a signifi-
cantly reduced risk association was observed both in the
linear estimates [HR (95% CI) = 0.91 (0.84–0.98)] and
across adherence categories when comparing the highest
versus the lowest adherence group [HR (95% CI) = 0.70
(0.52–0.95)] (Table 3).
Table 2 Baseline daily dietary intake for patients with stable angina pectoris calculated from a food frequency questionnaire
Dietary intake All n = 2019
Healthy Nordic Food Index groups
P-trend†
0–1 (lowest)
n = 392 2–3 n = 903
4–6 (highest)
n = 724










Total fat 31.3 (5.4) 33.0 (5.7) 31.3 (5.4) 30.4 (5.0) <0.001
Saturated and trans fat 11.5 (2.6) 12.5 (2.8) 11.7 (2.6) 10.9 (2.3) <0.001
Monounsaturated fat 10.1 (1.9) 10.6 (2.0) 10.1 (1.9) 9.8 (1.8) <0.001
Polyunsaturated fat 7.1 (1.9) 7.2 (2.2) 7.0 (1.9) 7.1 (1.8) 0.7
Protein 16.9 (2.6) 16.3 (2.5) 16.8 (2.6) 17.4 (2.4) <0.001
Carbohydrate 49.7 (6.4) 48.4 (6.4) 49.8 (6.6) 50.3 (6.0) <0.001
Dietary fibre§ 12.2 (3.2) 10.1 (2.7) 12.0 (2.9) 13.6 (3.2) <0.001
Food items (g day1 1000 kcal1)
Fish¶ 53.5 (28.3) 39.6 (23.3) 51.4 (28.5) 63.7 (26.7) <0.001
Olive oil 0.28 (0.29) 0.29 (0.33) 0.31 (0.30) 0.33 (0.24) 0.03
Red meat 25.7 (14.1) 26.8 (16.0) 25.3 (13.7) 25.5 (13.5) 0.2
Processed meat 28.8 (15.6) 33.4 (18.1) 29.5 (15.3) 25.4 (13.6) <0.001
Cheese 13.2 (11.8) 14.4 (13.3) 13.6 (12.2) 12.2 (10.4) 0.002
Milk 152 (109) 162 (125) 151 (109) 148 (98.0) 0.06
Butter and margarine 2.7 (3.9) 3.2 (5.0) 2.8 (3.9) 2.2 (3.1) <0.001
Egg 8.4 (6.1) 9.3 (7.1) 8.7 (6.3) 7.4 (5.0) 0.06
Potatoes 64.4 (33.8) 64.6 (38.0) 66.4 (35.0) 61.6 (29.3) <0.001
White bread 37.2 (36.8) 61.7 (40.7) 38.3 (36.4) 22.5 (26.4) <0.001
Whole grain bread 55.0 (46.7) 32.5 (47.5) 53.8 (47.8) 68.5 (39.3) <0.001
Vegetables 105 (74.1) 66.0 (48.3) 101 (71.5) 133 (77.9) <0.001
Fruits and berries 83.5 (63.7) 53.7 (50.1) 81.9 (62.8) 102 (64.9) <0.001
Cakes 13.4 (12.4) 12.6 (11.9) 13.5 (12.6) 13.9 (12.4) 0.1
Sugar and sweets 4.7 (6.1) 5.4 (6.8) 4.7 (6.2) 4.2 (5.4) 0.001
Alcoholk 1.4 [<0.001 and 2.4] 1.34 [<0.001 and 4.4] 1.43 [<0.001 and 4.1] 1.44 [0.08 and 3.8] 0.02
*Mean (SD) (all such values).
†Calculated by using linear regression. P-trend for Healthy Nordic Food Index (HNFI) groups 0-1, 2-3 and 4-6.
‡E%, percentage of total energy.
§Estimated in g day11000 kcal1.
¶Includes fish and shellfish.
kMedian and percentiles [25th and 75th].
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In analyses stratified by sex (see Supporting informa-
tion, Table S4), we observed no significant interaction by
sex for AMI. However, there was a significant interaction
by sex for cardiovascular (P = 0.004) and all-cause death
(P < 0.001), with stronger protective effects of a high
HNFI adherence among women than for men. The crude
event-free survival time for each outcome stratified by sex
is shown in the Supporting information (Fig. S1). The
Kaplan–Meier curves were significantly different only for
all-cause death.
Discussion
To our knowledge, this is the first study evaluating the
HNFI with respect to clinical outcomes in patients with
established CAD. In this prospective cohort study among
Norwegian men and women with stable angina pectoris, a
higher adherence to the HNFI was statistically significantly
associated with a reduced mortality risk. A similar associa-
tion was detected for cardiovascular death. However, no
significant association with the subsequent risk of AMI was
detected. For both CVD and total death, we observed a sig-
nificant modification by sex, with a stronger and more pro-
tective effect of a high HNFI adherence among women.
We observed distinct associations between adherence to
the HNFI score groups and other dietary habits. In par-
ticular, participants with a high adherence to the HNFI
had a significantly lower percentage intake of fat and a
higher fibre intake than those with a low adherence. Con-
currently, they had lower SFA intake as a result of a lower
intake of SFA-containing foods such as butter, cheese,
milk and processed meat. Although their intake of sugar
and sweets was low, they had higher intakes of vegetables,
fruit and berries, and whole grain bread, contributing to
the high fibre intake in those with a high adherence.
These differences in the mentioned food items were
expected as a result of the construction of the dietary
index (22).
A high intake of whole grains has been reported to be
protective against CVD (40); a high intake of fruits and
Table 3 Adjusted hazard ratios (HRs) [95% confidence interval (CI)] for acute myocardial infarction (AMI), cardiovascular death and all-cause
death according to level of adherence to the Healthy Nordic Food Index (HNFI) for stable angina pectoris patients*
Events, n Model 1† HR (95% CI) Model 2‡ HR (95% CI) Model 3§ HR (95% CI)
AMI 307
HNFI – linear estimate¶ 0.95 (0.86–1.05) 0.97 (0.89–1.05) 0.99 (0.91–1.08)
P for trend 0.32 0.47 0.84
HNFI – categories
0–1 points (reference) 70 1.00 1.00 1.00
2–3 points 135 0.81 (0.61–1.09) 0.85 (0.63–1.14) 0.88 (0.65–1.18)
4–6 points 102 0.76 (0.56–1.03) 0.83 (0.60–1.14) 0.90 (0.65–1.25)
P for trendk 0.16 0.28 0.59
Cardiovascular death 171
HNFI – linear estimate¶ 0.85 (0.77–0.94) 0.87 (0.78–0.96) 0.90 (0.81–1.01)
P for trend 0.002 0.009 0.06
HNFI – categories
0–1 points (reference) 38 1.00 1.00 1.00
2–3 points 84 0.83 (0.56–1.21) 0.86 (0.58–1.26) 0.92 (0.62–1.36)
4–6 points 49 0.56 (0.37–0.86) 0.61 (0.39–0.96) 0.71 (0.45–1.11)
P for trendk 0.005 0.024 0.17
All-cause death 380
HNFI – linear estimate¶ 0.87 (0.81–0.93) 0.87 (0.81–0.94) 0.91 (0.84–0.98)
P for trend ˂0.001 ˂ 0.001 0.009
HNFI – categories
0–1 points (reference) 84 1.00 1.00 1.00
2–3 points 184 0.83 (0.64–1.08) 0.84 (0.65–1.10) 0.91 (0.70–1.19)
4–6 points 112 0.59 (0.44–0.78) 0.61 (0.45–0.82) 0.70 (0.52–0.95)
P for trendk ˂0.001 0.001 0.017
*CIs were calculated with use of Cox proportional hazards; n = 2019.
†Adjusted for age and sex.
‡Adjusted for age, sex and total energy intake.
§Adjusted for age, sex, total energy intake, alcohol intake, diabetes, hypertension, physical activity, current smoking and statin treatment.
¶From linear estimates (per 1-point higher score).
kFrom linear analysis, calculated across adherence categories.
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berries as well as vegetables has been associated with
low CVD and mortality risk (41,42). Moreover, patients
with a high HNFI also had lower blood lipids despite
similar exposure to statins. A low intake of SFA was one
of the most obvious dietary differences between patients
with high versus low adherence. In addition, partici-
pants with a high adherence had a higher intake of fish,
as also associated with low CVD risk and low mortality
risk (3,43).
Participants with a high versus a low adherence to the
HNFI were different with regard to several cardiovascular
risk factors and lifestyle characteristics. They were less
likely to be smokers and were physically more active than
those with a low adherence. The latter may explain why
participants with a high adherence had a body mass index
similar to those with a low adherence despite a higher
energy intake. A similar finding was reported by Roswall
et al. (22) in healthy participants. Because data on physical
activity were self-reported, it was not possible to calculate
the energy cost of these extra activities. However, this
highlights the importance of physical activity being asso-
ciated with low mortality (44–46).
To summarise, positive associations with lifestyle fac-
tors in combination with a healthy diet may explain the
observed inverse association between HNFI adherence
and cardiovascular and total mortality. However, the lack
of any effect of the HNFI on AMI occurrence is difficult
to explain, although it may be a result of the extensive
treatment with statins. There was limited power to detect
significant differential associations between HNFI and the
outcomes fatal and nonfatal AMI separately because of a
low number of fatal AMIs.
Our results for outcomes of cardiovascular death and
all-cause death are in line with several other studies on
the HNFI conducted mainly in healthy subjects (14,32,47).
However, our findings with respect to the outcomes of
AMI are in contrast to those of a recent Danish study
based on a healthy population, in which it was shown
that high adherence to the HNFI was associated with a
lower risk of myocardial infarction among both men and
women (23).
Compared to the HNFI, there is ample evidence that a
Mediterranean Diet score is protective against CVD mor-
bidity and mortality primarily in the general population.
Studies of the Mediterranean Diet have been conducted
in several settings around the world (48–51) and have
mostly reported significant reductions in risk of coronary
heart disease (10), CVD progression (52), AMI (50) and
mortality (13). A recent review by Mattioli et al. (52)
declared that there is insufficient evidence for any clear
positive effects as a result of following a Mediterranean
Diet on CVD outcomes among patients with established
coronary heart disease.
By contrast to the HNFI, the Mediterranean Diet score
includes nine food groups and nutrients that are either
positively or negatively associated with health effects (53).
Some of these food groups, which are traditionally highly
consumed in the Mediterranean areas, in particular, olive
oil and legumes, are consumed at very low levels in the
Nordic countries (compare Table 2 for olive oil intake in
our population). In comparison to the Mediterranean
index, the HNFI may capture only partly a Healthy Nor-
dic diet because it does not contain any information on
intake of meat and edible oils. Thus, the absence of cer-
tain food items or nutrients that contribute to energy
intake clearly features some limitations with respect to
this index. This might explain why we did not identify
any association between HNFI adherence and AMI.
Nutraceuticals have been described as useful com-
pounds that are able to reduce the overall cardiovascular
risk caused by dyslipidaemia by acting in parallel to sta-
tins or as adjuvants in the case of failure or in situations
where statins cannot be used (54). However, the underly-
ing mechanisms are not fully understood but may be
related to reducing 7a-hydroxylase, decreasing 3-hydroxy-
3-methylglutaryl-CoA reductase mRNA levels, reducing
the secretion of very low-density lipoprotein or increasing
the faecal excretion of cholesterol (54). As described by
Scicchitano et al. (54), nutraceuticals are presented at high
levels in fish, fruits and vegetables. Because these food
items form the basis for the HNFI (fish, apples and pears,
root vegetables and cabbages), they may possibly play a
part in the associations between the HNFI and outcomes.
Future studies should thus explore whether risk
associations of the HNFI may be mediated by
nutraceuticals.
One particularly strong feature of the present study was
the inclusion of both men and women. We observed a
significantly stronger inverse association between the
HNFI and mortality in women compared to men. This
should motivate future studies on sex differences of diet-
ary patterns in relation to CVD development. Moreover,
linkage to the CVDNOR project and the Cause of Death
registry assured an almost complete follow-up. Other
strengths included detailed information on potential con-
founders such as lifestyle, cardiovascular history and the
results from cardiac examinations, as well as medication.
However, the information on lifestyle was self-reported
and information bias cannot be ruled out. Use of the
FFQ is easy, even for large populations, in that it requires
simple administration, has a rather low respondent bur-
den and may capture foods eaten rarely.
Some limitations of the present study also need to be
addressed. Dietary intake was only assessed at baseline,
and dietary habits may have changed during the long fol-
low-up period and not been captured by the analysis. In
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general, data obtained from the FFQ have the potential to
be limited by the foods included, as well as by misclassifi-
cation of dietary intake and estimation of portion sizes.
The FFQ also has less sensitivity compared to a 24-h diet-
ary recall (55). However, to capture the usual diet, more
than one 24-h diet recall would have been required,
which was by far beyond the capacity of the study centre.
Because our study originally included more than 3000
patients, administering a FFQ is the only method for
obtaining valid data on habitual diet. This is in line with
other studies on dietary patterns, including the Mediter-
ranean diet amongst others (13,14,22,23). In addition, the
FFQ that was used has been validated previously (28–31).
Furthermore, the willingness of the participants to pro-
vide information on a realistic dietary consumption can be
biased; for example, obese individuals and especially women
often under-report their total energy intake (56). Because the
majority of participants were men (81%), this factor may
be less important for the present study. Notably, the stron-
gest risk associations were observed among women, suggest-
ing that misclassification of data relevant to the HNFI was
not a greater problem in women. Furthermore, we observed
no association between the HNFI and waist circumference,
which therefore did not materially influence our results.
Because our study started before the HNFI was developed
(14), the FFQ used in the present study was not specifically
developed for use of the HNFI index. This is illustrated by
the replacement of rye bread in the original index by whole
grain bread in our analysis. Certainly, rye bread is common
in Denmark but not in Norway (57–59).
We only had self-reported data on physical activity and
a larger proportion (21.4%) had missing information.
Furthermore, self-reported data on physical activity may
not be accurate and reliable and have been shown to
result in both higher and lower levels of physical activity
than actually measured directly (60). Thus, residual con-
founding because of inadequate data ragarding physical
activity cannot be excluded. Finally, the potential effect
modification by physical activity should be evaluated in
future studies. Data on socio-economic status were not
available for the majority of the study participants and
this might have increased the probability for residual con-
founding by non-nutritional factors.
Because the present study cohort consisted mainly of
elderly male patients who had established atherosclerotic
disease and were therefore being treated with various
medications, the results may not be generalised to a
younger or a healthy, general population.
In conclusion, adherence to the HNFI was associated
with low risk of mortality among patients with stable
angina pectoris. There was no significant association with
risk of AMI. This highlights the importance of dietary
habits in this patient group, with other dietary patterns
besides the Mediterranean Diet possibly having positive
health effects in these patients. However, the HNFI may
need further refinement to provide a more representative
dietary profile.
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